US pharmaceutical company Bristol-Myers Squibb (BMS) quietly announced late Friday its strategy plans for access to daclatasvir, one of the new direct-acting antiviral (DAA) drugs used to treat ...
PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (BMY) (NYSE: BMY, “BMS”) today announced an agreement with the U.S. government to provide Eliquis ® (apixaban), an oral anticoagulant relied ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results